LED Dental Partners With London Drugs to Facilitate Oral Cancer Screenings for General Public

LED Dental Inc. , a wholly-owned Canadian operating subsidiary of LED Medical Diagnostics Inc. , is partnering with London Drugs to provide its VELscopeA Vx Enhanced Oral Assessment Systems for a pilot program for oral cancer screenings. The pilot program will be conducted by dental professionals on April 14th, April 15th and April 17th at twelve London Drug pharmacies in the lower mainland of B.C. Canada and has been endorsed by the BC Oral Cancer Prevention Program and developed with oral medicine and pathology specialist Dr. Samson Ng of UBC.

http://ift.tt/1CPhL5T